Medical travel patterns for hepatocellular carcinoma treatment in South Korea: National Health Insurance data from 2013 to 2021

doi:10.4251/wjgo.v17.i9.109060

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 9

This Article

(46)

(55)

(0)

(742)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastrointest Oncol. Sep 15, 2025; 17(9): 109060
Published online Sep 15, 2025. doi: 10.4251/wjgo.v17.i9.109060

Full Size Figure Download Figure

Figure 3 Medical travel of patients with hepatocellular carcinoma. A: Out of the region (efflux) for treatment; B: Into the region (influx) for treatment; C: Proportion of patients who traveled out of diagnosed areas; D: Proportion of patients who traveled to different regions for management.

Citation: Kim S, Kim N, Lee HS, Kim M, Kim H, Choi Y. Medical travel patterns for hepatocellular carcinoma treatment in South Korea: National Health Insurance data from 2013 to 2021. World J Gastrointest Oncol 2025; 17(9): 109060
URL: https://www.wjgnet.com/1948-5204/full/v17/i9/109060.htm
DOI: https://dx.doi.org/10.4251/wjgo.v17.i9.109060

Kim S, Kim N, Lee HS, Kim M, Kim H, Choi Y. Medical travel patterns for hepatocellular carcinoma treatment in South Korea: National Health Insurance data from 2013 to 2021. World J Gastrointest Oncol 2025; 17(9): 109060 [PMID: 40977650 DOI: 10.4251/wjgo.v17.i9.109060]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.